{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T17:48:51Z","timestamp":1792259331265,"version":"4.4.0"},"reference-count":67,"publisher":"Japanese Society for Magnetic Resonance in Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MRMS","magn reson med sci"],"published-print":{"date-parts":[[2022]]},"DOI":"10.2463\/mrms.rev.2021-0055","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T22:10:44Z","timestamp":1629497444000},"page":"9-28","source":"Crossref","is-referenced-by-count":21,"title":["&lt;sup&gt;1&lt;\/sup&gt;H-MR Spectroscopy of the Early Developmental Brain, Neonatal Encephalopathies, and Neurometabolic Disorders"],"prefix":"10.2463","volume":"21","author":[{"given":"Noriko","family":"Aida","sequence":"first","affiliation":[{"name":"Department of Radiology, Kanagawa Children\u2019s Medical Center"},{"name":"Department of Diagnostic Radiology, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1295","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Oz G, Alger JR, Barker PB, et al. MRS Consensus Group. Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014; 270:658\u2013679.","DOI":"10.1148\/radiol.13130531"},{"key":"2","unstructured":"2. Barkovich MJ, Barkovich AJ. Normal Development of the fetal, neonatal, and infant brain, skull, and spine, In: Barkovich AJ, Rayboud C eds. Pediatric neuroimaging, 6th ed. Philadelphia:Wolters Kluwer, 2019; 18\u201380."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Panigrahy A, Nelson MD Jr, Bl\u00fcml S. Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. Pediatr Radiol 2010; 40:3\u201330.","DOI":"10.1007\/s00247-009-1450-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Barta H, Jermendy A, Kolossvary M, et al. Prognostic value of early, conventional proton magnetic resonance spectroscopy in cooled asphyxiated infants. BMC Pediatr 2018; 18:302.","DOI":"10.1186\/s12887-018-1269-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Manias KA, Peet A. What is MR spectroscopy? Arch Dis Child Educ Pract Ed 2018; 103:213\u2013216.","DOI":"10.1136\/archdischild-2017-312839"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tomiyasu M, Harada M. <i>In vivo<\/i> human MR spectroscopy using a clinical scanner: development, applications and future prospects. Magn Reson Med Sci 2022; 21:235\u2013252.","DOI":"10.2463\/mrms.rev.2021-0085"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mascalchi M, Montomoli M, Guerrini R. Neuroimaging in mitochondrial disorders. Essays Biochem 2018; 62:409\u2013421.","DOI":"10.1042\/EBC20170109"},{"key":"8","unstructured":"8. Panigrahy A, Krieger MD, Gonzalez-Gomez I, et al. Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR Am J Neuroradiol 2006; 27:560\u2013572."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ho ML, Campeau NG, Ngo TD, et al. Pediatric brain MRI, Part 2: advanced techniques. Pediatr Radiol 2017; 47:544\u2013555.","DOI":"10.1007\/s00247-017-3792-2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bray MD, Mullins ME. Metabolic white matter diseases and the utility of MR spectroscopy. Radiol Clin North Am 2014; 52:403\u2013411.","DOI":"10.1016\/j.rcl.2013.11.012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kreis R, Ernst T, Ross BD. Development of the human brain: <i>in vivo<\/i> quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993; 30:424\u2013437.","DOI":"10.1002\/mrm.1910300405"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tochitani S. Functions of maternally-derived taurine in fetal and neonatal brain development, In: Lee DH Schaffer SW Park E, Kim HW eds. Taurine 10. Dordrecht:Springer, 2017; 17\u201325.","DOI":"10.1007\/978-94-024-1079-2_2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tomiyasu M, Aida N, Endo M, et al. Neonatal brain metabolite concentrations: an <i>in vivo<\/i> magnetic resonance spectroscopy study with a clinical MR system at 3 Tesla. PLoS One 2013; 8:e82746.","DOI":"10.1371\/journal.pone.0082746"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tomiyasu M, Aida N, Shibasaki J, et al. Normal lactate concentration range in the neonatal brain. Magn Reson Imaging 2016; 34:1269\u20131273.","DOI":"10.1016\/j.mri.2016.07.006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Volpe JJ. Neonatal encephalopathy: an inadequate term for hypoxic-ischemic encephalopathy. Ann Neurol 2012; 72:156\u2013166.","DOI":"10.1002\/ana.23647"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Executive summary: Neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Neonatal Encephalopathy. Obstet Gynecol 2014; 123:896\u2013901.","DOI":"10.1097\/01.AOG.0000445580.65983.d2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Jacobs SE, Berg M, Hunt R, et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013; 2013:CD003311.","DOI":"10.1002\/14651858.CD003311.pub3"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Laptook AR, Shankaran S, Tyson JE, et al. Eunice Kennedy Shriver national institute of child health and human development neonatal research network. Effect of therapeutic hypothermia initiated after 6 hrs of age on death or disability among newborns with hypoxic-ischemic encephalopathy: a randomized clinical trial. JAMA 2017; 318:1550\u20131560.","DOI":"10.1001\/jama.2017.14972"},{"key":"19","unstructured":"19. Schwartz ES, Barkovich AJ. Brain and spine injuries in infancy and childhood, In: Barkovich AJ, Rayboud C eds. Pediatric neuroimaging, 6th ed. Philadelphia:Wolters Kluwer, 2019; 263\u2013404."},{"key":"20","unstructured":"20. Aida N, Nishimura G, Hachiya Y, et al. MR imaging of perinatal brain damage: comparison of clinical outcome with initial and follow-up MR findings. AJNR Am J Neuroradiol 1998; 19:1909\u20131921."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rutherford M, Counsell S, Allsop J, et al. Diffusion-weighted magnetic resonance imaging in term perinatal brain injury: a comparison with site of lesion and time from birth. Pediatrics 2004; 114:1004\u20131014.","DOI":"10.1542\/peds.2004-0222"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Alderliesten T, de Vries LS, Staats L, et al. MRI and spectroscopy in (near) term neonates with perinatal asphyxia and therapeutic hypothermia. Arch Dis Child Fetal Neonatal Ed 2017; 102:F147\u2013F152.","DOI":"10.1136\/archdischild-2016-310514"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Boichot C, Walker PM, Durand C, et al. Term neonate prognoses after perinatal asphyxia: contributions of MR imaging, MR spectroscopy, relaxation times, and apparent diffusion coefficients. Radiology 2006; 239:839\u2013848.","DOI":"10.1148\/radiol.2393050027"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Okabe T, Aida N, Niwa T, et al. Early magnetic resonance detection of cortical necrosis and acute network injury associated with neonatal and infantile cerebral infarction. Pediatr Radiol 2014; 44:597\u2013604.","DOI":"10.1007\/s00247-013-2846-3"},{"key":"25","unstructured":"25. Cheong JL, Cady EB, Penrice J, et al. Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: metabolite peak-area ratios, relaxation times, and absolute concentrations. AJNR Am J Neuroradiol 2006; 27:1546\u20131554."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bednarek N, Mathur A, Inder T, et al. Impact of therapeutic hypothermia on MRI diffusion changes in neonatal encephalopathy. Neurology 2012; 78:1420\u20131427.","DOI":"10.1212\/WNL.0b013e318253d589"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Winter JD, Lee DS, Hung RM, et al. Apparent diffusion coefficient pseudonormalization time in neonatal hypoxic-ischemic encephalopathy. Pediatr Neurol 2007; 37:255\u2013262.","DOI":"10.1016\/j.pediatrneurol.2007.06.005"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Thayyil S, Chandrasekaran M, Taylor A, et al. Cerebral magnetic resonance biomarkers in neonatal encephalopathy: a meta-analysis. Pediatrics 2010; 125:e382\u2013395.","DOI":"10.1542\/peds.2009-1046"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Shibasaki J, Aida N, Morisaki N, et al. Changes in brain metabolite concentrations after neonatal hypoxic-ischemic encephalopathy. Radiology 2018; 288:840\u2013848.","DOI":"10.1148\/radiol.2018172083"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Lally PJ, Montaldo P, Oliveira V, et al. MARBLE consortium. Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multicentre cohort study. Lancet Neurol 2019; 18:35\u201345.","DOI":"10.1016\/S1474-4422(18)30325-9"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Poretti A, Blaser SI, Lequin MH, et al. Neonatal neuroimaging findings in inborn errors of metabolism. J Magn Reson Imaging 2013; 37:294\u2013312.","DOI":"10.1002\/jmri.23693"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Schneider JF. MR spectroscopy in children: protocols and pitfalls in non-tumorous brain pathology. Pediatr Radiol 2016; 46:963\u2013982.","DOI":"10.1007\/s00247-014-3270-z"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Morton DH, Strauss KA, Robinson DL, et al. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics 2002; 109:999\u20131008.","DOI":"10.1542\/peds.109.6.999"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Naughten ER, Jenkins J, Francis DE, et al. Outcome of maple syrup urine disease. Arch Dis Child 1982; 57:918\u2013921.","DOI":"10.1136\/adc.57.12.918"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Jan W, Zimmerman RA, Wang ZJ, et al. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 2003; 45:393\u2013399.","DOI":"10.1007\/s00234-003-0955-7"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Heindel W, Kugel H, Wendel U, et al. Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease. Pediatr Radiol 1995; 25:296\u2013299.","DOI":"10.1007\/BF02011106"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Sato T, Muroya K, Hanakawa J, et al. Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis. Pediatr Int 2014; 56:112\u2013115.","DOI":"10.1111\/ped.12211"},{"key":"38","unstructured":"38. Hamosh A, Johnston MV. Nonketotic hyperglycinemia. In: Scriver C, Beaudet A, Valle D, et al. eds. The metabolic and molecular bases of inherited disease, 8th ed. New York:McGraw-Hill, 2001; 2065\u20132068."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Shah DK, Tingay DG, Fink AM, et al. Magnetic resonance imaging in neonatal nonketotic hyperglycinemia. Pediatr Neurol 2005; 33:50\u201352.","DOI":"10.1016\/j.pediatrneurol.2005.01.002"},{"key":"40","unstructured":"40. Tomiyasu M, Shibasaki J, Kawai Y, et al. Quantification of brain glycine in an infant with nonketotic hyperglycemia: a serial proton magnetic resonance spectroscopy study. Proceedings of the 28th annual meeting of ISMRM 2020, Paris, 2020; 4678."},{"key":"41","unstructured":"41. Barkovich AJ, Patay Z. Metabolic, toxic, and autoimmune\/inflammatory brain disorders, In: Barkovich AJ Rayboud C eds. Pediatric neuroimaging, 6th ed. Philadelphia:Wolters Kluwer, 2019; 81\u2013262."},{"key":"42","unstructured":"42. Trinh BC, Melhem ER, Barker PB. Multi-slice proton MR spectroscopy and diffusion-weighted imaging in methylmalonic acidemia: report of two cases and review of the literature. AJNR Am J Neuroradiol 2001; 22:831\u2013833."},{"key":"43","unstructured":"43. Aida N, Tomiyasu M, Hanakawa J, et al. MRI and MRS findings in neonates with methylmalonic acidemia. Proceedings of the 46th annual meeting of JSNR, Tokyo, 2017; 77."},{"key":"44","unstructured":"44. Takanashi J, Barkovich AJ, Cheng SF, et al. Brain MR imaging in neonatal hyperammonemic encephalopathy resulting from proximal urea cycle disorders. AJNR Am J Neuroradiol 2003; 24:1184\u20131187."},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Gropman A. Brain imaging in urea cycle disorders. Mol Genet Metab 2010; 100 (Suppl 1):S20\u201330.","DOI":"10.1016\/j.ymgme.2010.01.017"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion 2008; 8:396\u2013413.","DOI":"10.1016\/j.mito.2008.05.003"},{"key":"47","unstructured":"47. Farina L, Chiapparini L, Uziel G, et al. MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations. AJNR Am J Neuroradiol 2002; 23:1095\u20131100."},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Mitani T, Aida N, Tomiyasu M, et al. Transient ischemic attack-like episodes without stroke-like lesions in MELAS. Pediatr Radiol 2013; 43:1400\u20131403.","DOI":"10.1007\/s00247-013-2661-x"},{"key":"49","unstructured":"49. Aida N. MELAS (Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes), In: Aoki S, Aida N, Ida M, Oba H, eds. Well-understandable brain MRI, 4th ed. Tokyo:Gakken Medical Shujunsha, 2020; 452\u2013453. (in Japanese)"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Koenig MK, Hodgeman R, Riviello JJ, et al. Phenotype of GABA-transaminase deficiency. Neurology 2017; 88:1919\u20131924.","DOI":"10.1212\/WNL.0000000000003936"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Tsuji M, Aida N, Obata T, et al. A new case of GABA transaminase deficiency facilitated by proton MR spectroscopy. J Inherit Metab Dis 2010; 33:85\u201390.","DOI":"10.1007\/s10545-009-9022-9"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Ichikawa K, Tsuji M, Tsuyusaki Y, et al. Serial magnetic resonance imaging and <sup>1<\/sup>H-Magnetic resonance spectroscopy in GABA transaminase deficiency: a case report. JIMD Rep. 2019; 43:7\u201312.","DOI":"10.1007\/8904_2018_95"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Provencher SW. Estimation of metabolite concentrations from localized <i>in vivo<\/i> proton NMR spectra. Magn Reson Med 1993; 30:672\u2013679.","DOI":"10.1002\/mrm.1910300604"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Tachibana Y, Aida N, Enomoto K, et al. A case of Sj\u00f6gren-Larsson syndrome with minimal MR imaging findings facilitated by proton spectroscopy. Pediatr Radiol 2012; 42:380\u2013382.","DOI":"10.1007\/s00247-011-2156-6"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Osaka H, Takagi A, Tsuyusaki Y, et al. Contiguous deletion of SLC6A8 and BAP31 in a patient with severe dystonia and sensorineural deafness. Mol Genet Metab 2012; 106:43\u201347.","DOI":"10.1016\/j.ymgme.2012.02.018"},{"key":"56","unstructured":"56. Mano T, Ono J, Kaminaga T, et al. Proton MR spectroscopy of Sj\u00f6gren-Larsson\u2019s syndrome. AJNR Am J Neuroradiol 1999; 20:1671\u20131673."},{"key":"57","unstructured":"57. Willemsen MA, Van Der Graaf M, Van Der Knaap MS, et al. MR imaging and proton MR spectroscopic studies in Sj\u00f6gren-Larsson syndrome: characterization of the leukoencephalopathy. AJNR Am J Neuroradiol 2004; 25:649\u2013657."},{"key":"58","unstructured":"58. Adam MP, Ardinger HH, Pagon RA, et al. editors. GeneReviews<sup>\u00ae<\/sup>. Seattle: Universityof Washington, 1993-2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1116\/. (Accessed: March 22, 2021)"},{"key":"59","unstructured":"59. Aida N, Tomiyasu M, Enokizono M, et al. MRI\/MRS findings of cerebral creatine deficiencies. Proceedings of the 43rd annual meeting of JSMRM, Tokyo, 2015; 173."},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Clark AJ, Rosenberg EH, Almeida LS, et al. X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology. Hum Genet 2006; 119:604\u2013610.","DOI":"10.1007\/s00439-006-0162-9"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Rosenberg EH, Almeida LS, Kleefstra T, et al. High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet 2004; 75:97\u2013105.","DOI":"10.1086\/422102"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Newmeyer A, deGrauw T, Clark J, et al. Screening of male patients with autism spectrum disorder for creatine transporter deficiency. Neuropediatrics 2007; 38:310\u2013312.","DOI":"10.1055\/s-2008-1065353"},{"key":"63","unstructured":"63. Wada T. Summary in clinical research of cerebral creatine deficiency syndromes supported by Japan Ministry of health, labor and welfare scientific research grant 2015. https:\/\/research-er.jp\/projects\/view\/918118. (Accessed: March 22, 2021)"},{"key":"64","unstructured":"64. Bianchi MC, Tosetti M, Battini R, et al. Treatment monitoring of brain creatine deficiency syndromes: a <sup>1<\/sup>H- and <sup>31<\/sup>P-MR spectroscopy study. AJNR Am J Neuroradiol 2007; 28:548\u2013554."},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Kurosawa Y, Degrauw TJ, Lindquist DM, et al. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency. J Clin Invest 2012; 122:2837\u20132846.","DOI":"10.1172\/JCI59373"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Akiyama T, Osaka H, Shimbo H, et al. A Japanese adult case of guanidinoacetate methyltransferase deficiency. JIMD Rep 2014; 12:65\u201369.","DOI":"10.1007\/8904_2013_245"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Steinfeld R, Grapp M, Kraetzner R, et al. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet 2009; 85:354\u2013363.","DOI":"10.1016\/j.ajhg.2009.08.005"}],"container-title":["Magnetic Resonance in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/21\/1\/21_rev.2021-0055\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:40:28Z","timestamp":1715233228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/21\/1\/21_rev.2021-0055\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2463\/mrms.rev.2021-0055","relation":{},"ISSN":["1347-3182","1880-2206"],"issn-type":[{"value":"1347-3182","type":"print"},{"value":"1880-2206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"rev.2021-0055"}}